5 Results for "

Gardiquimod

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Gardiquimod" in MCE Product Catalog:

Cat. No.: HY-103697
CAS No.: 1020412-43-4
Purity:  99.91%
Research Areas:  

Cancer

Gardiquimod is an imidazoline TLR7/8 agonist. Gardiquimod inhibits HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod specifically activates TLR7 at concentrations below 10 μM.
loading...
    loading...
Cat. No.: HY-103697A
CAS No.: 1159840-61-5
Purity:  ≥99.0%
Research Areas:  

Cancer

Gardiquimod diTFA is an imidazoline TLR7/8 agonist. Gardiquimod diTFA inhibits HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod diTFA specifically activates TLR7 at concentrations below 10 μM.
loading...
    loading...
Cat. No.: HY-103697R
CAS No.: 1020412-43-4
Research Areas:  

Cancer

Gardiquimod (Standard) is the analytical standard of Gardiquimod. This product is intended for research and analytical applications. Gardiquimod is an imidazoline TLR7/8 agonist. Gardiquimod inhibits HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod specifically activates TLR7 at concentrations below 10 μM.
loading...
    loading...
Cat. No.: HY-103697B
CAS No.: 2956183-81-4
Research Areas:  

Infection Cancer

Gardiquimod (hydrochloride) is an imidazoline TLR7/8 agonist. Gardiquimod (hydrochloride) inhibits HIV-1 infection of macrophages and activates peripheral blood mononuclear cells (PBMCs). Gardiquimod (hydrochloride) specifically activates TLR7 at concentrations below 10 μM .
loading...
    loading...
Cat. No.: HY-103697AR
CAS No.: 1159840-61-5
Research Areas:  

Cancer

Gardiquimod (diTFA) (Standard) is the analytical standard of Gardiquimod (diTFA). This product is intended for research and analytical applications. Gardiquimod diTFA is an imidazoline TLR7/8 agonist. Gardiquimod diTFA inhibits HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod diTFA specifically activates TLR7 at concentrations below 10 μM.
loading...
    loading...